Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 31 December 2025

Oklo stock slips today after SEC filings show insiders moved 15 million OKLO shares into trusts

Oklo stock slips today after SEC filings show insiders moved 15 million OKLO shares into trusts

NEW YORK, December 31, 2025, 3:29 PM ET — Regular session Oklo Inc. shares slipped on Wednesday after regulatory filings showed the nuclear startup’s top executives shifted large blocks of stock into family and estate-planning trusts. The disclosures matter because Oklo’s shares have been volatile, and trading has often been sensitive to insider activity and potential dilution at early-stage companies that are still working toward commercial deployment. They also land as investors reassess the pace of U.S. nuclear buildout and the long approval timelines that can make or break project schedules for advanced reactor developers. Oklo shares were down about
31 December 2025
····
CoreWeave stock drops as insider sale filing hits thin year-end trade — what’s next for CRWV

CoreWeave stock drops as insider sale filing hits thin year-end trade — what’s next for CRWV

NEW YORK, December 31, 2025, 14:40 ET — Regular session CoreWeave Inc shares were down 3.1% at $71.63 on Wednesday afternoon, after an insider sale disclosure drew attention in thin year-end trading. The stock hit a session low of $71.46. The timing matters because trading conditions are patchy heading into the New Year’s Day holiday, when lower liquidity can amplify moves in single names. For a recently listed company with a volatile tape, incremental supply can weigh on sentiment even without new fundamental news. Investors have also been sensitive to funding and dilution risk in capital-intensive AI infrastructure plays. CoreWeave
31 December 2025
····
Visa stock slips as escrow-linked share conversion update hits year-end trade

Visa stock slips as escrow-linked share conversion update hits year-end trade

NEW YORK, December 31, 2025, 14:37 ET — Regular session Visa Inc. shares edged lower on Wednesday, down $1.14, or 0.3%, at $352.48 in afternoon trading as investors digested a technical update tied to the payments giant’s U.S. litigation escrow account. The stock traded between $352.08 and $355.13. The filing matters because it highlights how Visa manages certain legacy legal exposures in the United States. Even mechanical changes that touch the share count can feed into earnings per share — a key yardstick for a company that returns significant capital to shareholders. The update also lands as traders position into
31 December 2025
····
Santa Claus Rally Fizzles: S&P 500, Dow Slip as Tech Weighs on 2025 Finale

Santa Claus Rally Fizzles: S&P 500, Dow Slip as Tech Weighs on 2025 Finale

NEW YORK, December 31, 2025, 13:55 ET Wall Street’s main indexes inched lower in the final trading session of 2025, pressured by technology shares, but remained on track to finish the year with solid gains. The late-year dip matters because it comes after a volatile year shaped by tariff uncertainty from President Donald Trump and a powerful run in artificial intelligence, or AI, stocks that pushed major indexes to record highs. It also puts a spotlight on the market’s failure to deliver a “Santa Claus rally” — the seasonal pattern when the S&P 500 often rises over the last five
31 December 2025
······
Tesla stock slips in premarket after Tesla posts downbeat delivery consensus ahead of Friday report

Tesla stock slips in premarket after Tesla posts downbeat delivery consensus ahead of Friday report

NEW YORK, December 31, 2025, 07:05 ET — Premarket Tesla shares edged lower in premarket trading on Wednesday after the electric-vehicle maker posted unusually pessimistic Wall Street delivery expectations on its investor relations site ahead of its quarterly report. Barron’s The publication matters because Tesla is expected to report fourth-quarter and annual production and delivery figures on Friday, and that print is the market’s fastest read on demand. Deliveries are the vehicles a carmaker hands to customers. Investing.com Tesla rarely puts sell-side forecasts in public view, and the move has sharpened investor focus on whether the company is trying to
31 December 2025
·····
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

NEW YORK, December 31, 2025, 05:39 ET — Premarket Shares of Hims & Hers Health Inc (HIMS) fell 0.5% to $32.87 in premarket trading on Wednesday after closing down 3.1% at $33.04 in the prior session. The stock has traded between $23.97 and $72.98 over the past 52 weeks. Google The drift lower keeps attention on the telehealth group’s exposure to the fast-moving market for GLP-1 weight-loss drugs — a category that has become a major battleground for pricing, access and consumer demand. That matters now because GLP-1 drugs, a class of diabetes and obesity medicines that reduce appetite, are
31 December 2025
·······
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

NEW YORK, December 31, 2025, 04:32 ET — Premarket Profusa Inc shares were down about 12% at 10.7 cents in premarket trading on Wednesday, after soaring 78% to 12.2 cents in the prior session as investors reacted to the company’s debt restructuring. Tuesday’s session saw the stock trade between 10.8 cents and 17 cents, with volume jumping to about 822 million shares. StockAnalysis The moves matter because Profusa is a thinly traded, penny-stock name where small shifts in financing terms can dominate price action. For existing shareholders, the central question is dilution — how many new shares might be created
31 December 2025
···
Bristol-Myers Squibb stock edges higher as Wall Street drifts into year-end — what’s next for BMY

Bristol-Myers Squibb stock edges higher as Wall Street drifts into year-end — what’s next for BMY

NEW YORK, December 30, 2025, 23:30 ET — Market closed Bristol-Myers Squibb Co. shares closed up 0.18% at $54.21 on Tuesday, after trading between $53.92 and $54.35. The stock has ranged from $42.52 to $63.33 over the past 52 weeks. Bristol Myers Squibb Investors The modest gain came as Wall Street drifted lower in holiday-thinned trade. “The growth rates are going to converge between technology and everything else next year,” said Mark Hackett, chief market strategist at Nationwide, as investors repositioned after a tech-led run; the S&P 500 slipped 0.14% and the Nasdaq fell 0.23%. Reuters Why it matters now:
31 December 2025
····
Carvana stock slips again as year-end trade thins out — what CVNA traders watch next

Carvana stock slips again as year-end trade thins out — what CVNA traders watch next

NEW YORK, December 30, 2025, 21:29 ET — Market closed Carvana Co. shares fell 0.9% on Tuesday to close at $429.55, after trading between $429.05 and $435.70. Volume was about 1.33 million shares, and the stock was little changed in after-hours trading, which takes place electronically after the 4 p.m. close. StockAnalysis The dip matters because Carvana has become a high-beta, heavily traded name after a sharp run this year, making it sensitive to shifts in risk appetite. The online used-car retailer also sits at the intersection of consumer demand and borrowing costs, with financing central to how many buyers
31 December 2025
····
Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

NEW YORK, December 30, 2025, 21:50 ET — Market closed Applied Materials, Inc. shares ended Tuesday down 1.17% at $259.97, snapping a seven-day winning streak for the chip-equipment maker. MarketWatch The move matters as investors head into the final trading day of 2025 with China policy and U.S. export controls back in focus for semiconductor tool suppliers. Applied makes chipmaking equipment — the high-precision tools used to deposit and remove materials on silicon wafers — a market where China remains a key buyer even as restrictions tighten. Reuters+1 After the close, Reuters reported that Chinese authorities are requiring chipmakers to
31 December 2025
······
Super Micro (SMCI) stock slips after ops-chief retirement filing; what traders watch next

Super Micro (SMCI) stock slips after ops-chief retirement filing; what traders watch next

NEW YORK, December 30, 2025, 20:14 ET — Market closed. Super Micro Computer (SMCI.O) shares closed down 1.4% at $29.65 on Tuesday after the server maker disclosed that its senior vice president of operations will retire at the end of 2025, according to a regulatory filing. Yahoo Finance+2Super Micro Computer+2 The timing puts fresh attention on execution at a company that depends on tight production schedules to ship high-end servers used in artificial intelligence data centers, with its December quarter ending on Wednesday. The stock’s move also came during a choppy, holiday-thin session that left major indexes slightly lower, with
31 December 2025
·····
Abbott stock today: ABT rises as Exact Sciences deal filing and Volt AFib device stay in focus

Abbott stock today: ABT rises as Exact Sciences deal filing and Volt AFib device stay in focus

NEW YORK, December 30, 2025, 19:51 ET — After-hours Abbott Laboratories (ABT.N) shares rose 0.97% to $125.78 in Tuesday’s regular session and held steady in after-hours trading. ABT quote The move lands as investors reprice 2026 catalysts for large-cap healthcare, where product cycles and deal timelines can matter more than day-to-day macro noise. Abbott has two big threads in play: a planned push deeper into cancer screening through a major acquisition and a newly cleared heart-rhythm device in a fast-developing market. Both can influence revenue mix and margins, which feed directly into valuation. In the broader tape, U.S. stocks ended
31 December 2025
····
1 … 77 78 79 80 81 … 282

Stock Market Today

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Go toTop